Last reviewed · How we verify
NCT05410340
EEG and NIRS in Preterm Infants
NA trial testing Vojta Therapy in Premature Birth in 80 participants. Enrolling by invitation.
2 October 2024
Quick facts
| Lead sponsor | University of Salamanca |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | screening |
| Enrollment | 80 |
| Start date | 3 August 2024 |
| Primary completion | 2 October 2024 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Vojta Therapy
- Massotherapy
Conditions studied
- Premature Birth — all drugs for Premature Birth →
Sponsor
University of Salamanca
Who can join
Adults 7 Days to 1 Month, any sex, with Premature Birth. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Experimental cross-sectional study of a single application (vojta therapy or massage) in preterm and non-preterm infants to test whether there are differences in brain activation and oxygenation that occur with both techniques between term and preterm infants. Secondly, the brain activation and oxygenation produced by both physiotherapy techniques will be tested separately to establish comparisons between the two groups. Finally, between 3 - 6 months, we will analyse whether there are changes in gaze fixation (eye tracker) in the 4 study arms to see if there are differences between term and preterm infants but also the differences between the immediate effectiveness of both techniques.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05410340
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vojta Therapy
Trials testing the same drug.
- NCT07248267 — Effects of Vojta Therapy on Functional Mobility and Gait Parameters in Children With Down Syndrome · NA · recruiting
- NCT06670092 — Effect of Vojta Therapy on Motor Control in Children With Attention Deficit Hyperactivity Disorder · NA · completed
- NCT05785962 — Electromyographic Control of the Response in the Application of Vojta Therapy in People With Brain Injury. · NA · terminated
- NCT06092619 — Effects of Vojta Therapy on the Motor Function of Children With Neuromotor Disorders · NA · unknown
- NCT06159426 — Expert vs. Non-expert Abdominal Electromyographic Control in Vojta Therapy · NA · unknown
Other recruiting trials for Premature Birth
Currently open trials in the same condition.
- NCT07490912 — Neonatal Data and Biobank to Study Factors Influencing Development in Preterm Infants Born at <32 Weeks' Gestation and/o · recruiting
- NCT07183462 — Azithromycin and Ampicillin for Late PPROM · Phase 4 · recruiting
- NCT07306793 — The Effect of PIOMI and Chronobiological Nutrition on Readiness for Feeding, Full Transition to Oral Feeding and Body We · NA · recruiting
- NCT06554522 — Pragmatic Evaluation of Respiratory Distress Syndrome Treatment in Africa · Phase 4 · recruiting
- NCT06340971 — Air Pollution and Pregnancy · recruiting
Other University of Salamanca trials
Trials by the same sponsor.
- NCT07359495 — Multicomponent Training and Muscle Quality in Older Women · NA · not yet recruiting
- NCT07286539 — Precision Physical Exercise for Personalized Onco-Hematology. · NA · not yet recruiting
- NCT07387770 — Muscle Deterioration in Hospitalized Cancer Patient · NA · not yet recruiting
- NCT07387757 — Exergames in Mental Health · NA · not yet recruiting
- NCT07333768 — EQUISOCK: New Antiequine · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05410340 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Salamanca
- Last refreshed: 22 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05410340.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing